domains. Strikingly, the disordered C-terminus in the apo-form reorganized into a highly-ordered loop and a β-strand G′′ covering the ligand upon ligand binding. Bbp Ala298-Gly301 in the N2 domain of the Bbp 273−598 -Fg α 561−575 complex, which is a loop in the apo-form, formed a short α-helix to interact tightly with the peptide. In addition, Bbp Ser547-Gln561 in the N3 domain moved toward the binding groove to make contact directly with the peptide, while Bbp Asp338-Gly355 and Bbp Thr365-Tyr387 in N2 domain shifted their configurations to stabilize the reorganized C-terminus mainly through strong hydrogen bonds. Altogether, our results revealed the molecular basis for Bbp-ligand interaction and advanced our understanding of S. aureus infection process.
INTRODUCTION
Staphylococcus aureus (S. aureus) has been one of the leading causes of bacterial infections worldwide. Each year, some 500,000 patients in United States' hospitals contract staphylococcal infections. S. aureus resides as part of the normal flora in the healthy human body until there is damage to skin surface or mucosal barrier, when it can gain access to tissues or the bloodstream, ultimately resulting in a wide range of infections and diseases, including impetigo, bacteremia, endocarditis, sepsis and arthritis (Lowy, 1998) . Several antibiotics have been introduced to successfully treat S. aureus infections in patients over the past few decades. However, the infections became a growing concern lately due to the emergence of highly virulent and antibioticresistant strains, leading to increased morbidity and mortality (Zetola et al., 2005) . Effective vaccines against S. aureus at early stages of infection are highly desirable, although all efforts to develop these vaccines have failed to date (Deresinski and Herrera, 2010; Vazquez et al., 2011) .
S. aureus has evolved multiple strategies to promote colonization and evade the immune system. The initial adhesion of the pathogen to the extracellular matrix (ECM) components of the host is believed to be a critical step for successful infection. This is mediated by S. aureus surface adhesins called Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) (Gillaspy et al., 1998; Patti et al., 1994) . Several structurally related proteins characterized by serine-aspartate dipeptide repeats (SD repeats) make up a family of MSCRAMMs (McCrea et al., 2000) . The serine-aspartate repeat (Sdr) family include SdrF and SdrG in S. epidermidis and clumping factor A (ClfA), ClfB, SdrC, SdrD, SdrE and Bbp in S. aureus (Josefsson et al., 1998; McDevitt et al., 1994; Ni Eidhin et al., 1998; Tung et al., 2000) . S. aureus bone sialoprotein-binding protein (Bbp) is an allelic variant of SdrE (Peacock et al., 2002) . The members of Sdr family are predicted to adopt a similar structural pattern (Trad et al., 2004) . A secretary signal sequence locates at the N-terminus followed by a ligandbinding A region and a characterized R region composed of SD repeats. The C-terminus features a cell wall-anchoring motif including the conserved LPXTG sequence (W), a hydrophobic membrane-spanning domain (M) and a short positively charged cytoplasmic tail (C) (Downer, 2002) . In addition, SdrC, SdrD, SdrE and Bbp have different numbers of B repeats inserted between region A and R with the presence of a well-defined 12 residues cation-binding EFhand loop (Josefsson et al., 1998) . Our recent work showed that B1 domain interacted with N2 domain and opened the ligand binding cleft between N2 and N3 domains in SdrD (Wang et al., 2013) .
The gene identified from chromosomal DNA isolated from S. aureus subsp. aureus TCH60 encodes bone sialoproteinbinding protein (Bbp) with 1149 amino acids, containing SDrepeats of 154 residues and the ligand-binding A region from 53 to 601 residues further divided into N1, N2 and N3 domains. S. aureus isolated from patients suffering from septic arthritis and osteomyelitis specifically interacts with bone sialoprotein (BSP), a noncollagenous protein of bone and dentine extracellular matrix, mediated by Bbp (Ganss et al., 1999; Ryden et al., 1987; Tung et al., 2000) . BSP is proposed to induce hydroxyapatite crystal formation and distributes predominantly in the newly formed bone, which is more likely to be infected (Hultenby, 1994; Hunter and Goldberg, 1993) .
Fibrinogen (Fg), a hexameric glycoprotein consisting of three different chains α 2 , β 2 and γ 2 , plays critical roles in blood clotting and thrombosis (Gailit et al., 1997; Kollman et al., 2009; Mosesson et al., 2001) . ClfB binds to fibrinogen α (Fg α) chain Xiang et al., 2012) . ClfA and the fibronectin-binding proteins FnbpA and FnbpB all bind to the C-terminal residues of fibrinogen γ (Fg γ) chain (Rivera et al., 2007; Wann et al., 2000) . SdrG is reported to attack the thrombin cleavage site of fibrinogen β (Fg β) chain (Davis et al., 2001) . A "dock, lock and latch" (DLL) model is identified in SdrG-Fg β complex to elucidate the ligand binding mechanism, where the ligand docks in the opened groove between N2 and N3 domains and the C-terminus across the groove stretches into N2 domain (Ponnuraj et al., 2003) .
As a bifunctional MSCRAMM, Bbp also recognizes the human Fg α chain and inhibits thrombin induced blood coagulation (Vazquez et al., 2011 additional residues Gly and Ser at N-terminus, two of the remaining five amino acid residues (GPLGS) from digested GST-tag (Fig. 1C) . No electron density was observed for the 14 residues at C-terminus in the apo-Bbp 273−598 structure.
The apo-Bbp 273−598 folds into two distinct domains N2 and N3, both of which have two layers of β-sheets and are structurally similar to the Dev-IgG fold (Fig. 1B) , a variant of IgG fold (Deivanayagam et al., 2002) . The two β-sheets of the N2 domain are composed of A, B and E strands on one side and C, D, D1, F and G strands on the opposite side. In N3 domain, C′, D1′, D2′, F′ and G′ strands form one principal sheet and A′, B′, D′ and E′ strands contribute to the facing sheet. The additional D1′ and D2′ strands present the featured Dev-IgG fold. One difference occurs with regard to the D strand in N2 domain, which parallels with E strand, although exhibiting an antiparallel orientation with the corresponding strand in the description of SdrG, ClfB and ClfA (Ganesh et al., 2008; Ponnuraj et al., 2003; Xiang et al., 2012) . In the apo-Bbp 273−598 structure, the C-terminus with poor electron density extends into the solvent region, thus leading to an open groove. Presumably, a ligand-binding site could exist in the groove. (All structural figures in this paper were generated by PyMOL). (McCrea et al., 2000) . The β-strand E moves toward β-strand G′′ to stabilize the C-terminus of N3 through several hydrogen bonds. Bbp C-terminus. Bbp Asp373 and Arg374 in this region form two hydrogen bonds with Bbp Lys597 to stabilize the tail of the reordered C-terminus (Fig. 4A ).
Structure of the Bbp
In addition, the binding of the peptide also induces a reorganization of the region Bbp Ala298-Gly301 between the A and B strands in N2 domain and a large movement of the region Bbp Ser547-Gln561 between the E′ and F′ strands in N3 domain toward the peptide binding groove. Two newly formed α-helices are observed in both of the two regions (Fig. 3B) (Fig. 4B ).
The structural rearrangements and the direct protein-ligand interactions formed upon peptide binding result in an effectively stabilized Bbp-Fg α complex compared to its apoform.
Structural insights into Bbp
273−598 and Fg α
561−575 interactions
Apart from the interactions between the Fg α 561−575 peptide and the residues from the two newly formed α-helices we have described above, there are several contacts with distances of less than 4 Å marked (Fig. 4B) In allowed regions 2.9 1.1
In disallowed regions 0.6 0.0
Values in parentheses are for the highest resolution shell. R = Σ|F obs − F calc |/Σ Fobs , where F calc is the calculated protein structure factor from the atomic model (R free was calculated with 5% of the reflections selected). protein. This is probably because the side chain of Ala occupies less space compared to Thr or Leu, which brings an alteration of steric hindrance. Thus, the alteration presumably makes the peptide more easily dock into the groove and contacts more tightly with Bbp 273−598 . Even though Bbp Thr582 and Leu584 could interact with the peptide by two pairs of main chain-main chain hydrogen bonds (Fig. 3C) , the replacement to alanine might serve a similar role instead of breaking the interaction with the peptide according to the results here. Perhaps, we can speculate that the residues Bbp Thr582 and Leu584 are only involved in the binding with the peptide, but not showing specificities on ligand recognition. on the structural information, we analyzed the structural basis for ligand binding. In our study, tight interactions between the protein and the ligand result in a stable binding state. Due to the "Dock" of the ligand, the rearrangements occur to C-terminus and additional four regions of Bbp 273−598 . The connecting loop covers the open groove, resulting in "Lock" of the ligand. And then the G′′ strand forms compact interactions with the E strand in the region Bbp Thr365-Tyr387 of N2 domain, which "Latch" the ligand binding site and thus stabilize the overall structure. Our structure further supports the DLL model described for the SdrG-Fg β complex (Fig. 6A) (Ponnuraj et al., 2003) .
In the work of V. Ganesh et al. on the ClfB-ligand complex, the ligand binding mechanism was described as the "DL" model due to the absence of the "Latch" process . In their structure, peptide Fg α 336−347 in ClfB adopts a reverse orientation compared to the peptide Fg α 561−575 in our structure. The C-terminus of ClfB does not stretch into N2 domain to interact with the E strand but exhibits a different direction. Upon ligand binding, no rearrangements are observed in the region between the D and D′ strands in N2 and the region between the E and F strands in N3 (Fig. 6B) . However, large movements occur to the corresponding regions Bbp Asp338-Gly355 in N2
and Bbp Ser547-Gln561 in N3 of Bbp 273−598 in our studies. The diversity of the ligands binding pattern of MSCRAMMs adds to the necessity for structural analysis of individual members of this family. Altogether, our findings have promoted the understanding of the ligand binding mechanism of Bbp in Sdr family, a critical step in the S. aureus infection process. In addition, potential new target sites based on these pathogen-host interactions could be explored for development of potent antibiotics and new therapeutic methods. 
MATERIALS AND METHODS
Cloning, expression and purification of the recombinant proteins
The fragment of the Bbp gene (corresponding to 273-598 aa) was amplified using S. aureus ATCC 25923 genomic DNA by PCR. The gene fragments of mutated proteins Bbp T582A and Bbp L584A followed the same protocol. After digestion with BamHI and XhoI (NEB), the amplified fragments were cloned into the prokaryotic expression vector pGEX-6p-1 (GE Healthcare Life Sciences) to produce the GST-Bbp fusion protein and were confirmed by DNA sequencing. The recombinant protein was expressed in Escherichia coli strain BL21 with a high yield. The bacteria cells were harvested and resuspended in lysis buffer containing 1× PBS, 2 mmol/L DTT and 1 mmol/L PMSF. The cells were homogenized by sonification and cell debris was removed completely by centrifuging at 13,000 rpm for 50 min at 4°C.
The recombinant protein was firstly purified by GST-affinity column and digested with PreScission protease overnight. The eluant was collected and concentrated for further purification using gel filtration chromatography (Superdex-200 column, GE Healthcare) in buffer containing 20 mmol/L HEPES pH 7.5, 200 mmol/L NaCl, 2 mmol/L DTT on the FPLC system (GE Healthcare Life Sciences). The proteins in every step of purification were analyzed by SDS-PAGE.
Crystallization and structure determination
The apo-Bbp 273−598 and its complex were concentrated to 30 mg/mL in 20 mmol/L HEPES pH 7.5, 200 mmol/L NaCl, 2 mmol/L DTT. Crystals were screened by the sitting-drop vapor diffusion method (Jancarik et al., 1991) using sparse-matrix screen kits Crystal Screen I and II (Hampton Research), followed by optimizing the crystallization conditions through the variation of protein concentrations and pH. Crystals were grown at 18°C using the hanging-drop vapor diffusion method by mixing 1. -peptide complex crystals diffracted to 2.03 Å and 1.45 Å respectively. The data were collected at the Shanghai Synchrotron Radiation Facility (SSRF) BL17U using a MAR225 (MAR Research, Hamburg) CCD detector at 100 K and processed with the HKL2000 package (Otwinowski and Minor, 1997) . Further processing was carried out using programs from the CCP4 suite (Collaborative Computational Project, 1994) . The model building of the Bbp 273−598 molecules was conducted in COOT and the structure with peptide was determined by molecular replacement methods in CCP4 (Emsley and Cowtan, 2004) . All the structures were refined with the PHENIX packages (Adams et al., 2002) . Data collection and structure statistic are summarized in Table 1 .
Synthesis of Fg α 561−575 chain peptide
The peptide corresponding to the fibrinogen α 561−575 was synthesized as previously described (Vazquez et al., 2011) .
Isothermal titration calorimetry
ITC experiments were carried out at 25°C using a Microcal iTC200 instrument (GE Healthcare). The cell contained 50 μmol/L Bbp 273−598 and the syringe contained 500 μmol/L peptide in the buffer containing 200 mmol/L NaCl and 20 mmol/L HEPES pH 7.5. Injecting peptide into buffer was performed as the blank titration. The data were fitted and analyzed using the Origin 7 software package (Microcal).
Surface plasmon resonance spectroscopy
The interaction affinities between Fg α 561−575 and Bbp 273−598 protein were conducted by surface plasmon resonance (SPR) using BIAcore T200 instrument (GE Healthcare). The wild type Bbp 
